Topical Versus Intravenous Tranexamic Acid in Patients Undergoing Cardiac Surgery: The DEPOSITION Randomized Controlled Trial
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, randomizované kontrolované studie, multicentrická studie, srovnávací studie
- Klíčová slova
- administration, intravenous, administration, topical, blood transfusion, seizures, thoracic surgery, tranexamic acid,
- MeSH
- antifibrinolytika * aplikace a dávkování škodlivé účinky terapeutické užití MeSH
- aplikace lokální * MeSH
- dvojitá slepá metoda MeSH
- intravenózní podání * MeSH
- kardiochirurgické výkony * škodlivé účinky MeSH
- krvácení při operaci prevence a kontrola MeSH
- kyselina tranexamová * aplikace a dávkování škodlivé účinky terapeutické užití MeSH
- lidé středního věku MeSH
- lidé MeSH
- senioři MeSH
- výsledek terapie MeSH
- záchvaty prevence a kontrola etiologie MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- randomizované kontrolované studie MeSH
- srovnávací studie MeSH
- Názvy látek
- antifibrinolytika * MeSH
- kyselina tranexamová * MeSH
BACKGROUND: Although intravenous tranexamic acid is used in cardiac surgery to reduce bleeding and transfusion, topical tranexamic acid results in lower plasma concentrations compared with intravenous tranexamic acid, which may lower the risk of seizures. We aimed to determine whether topical tranexamic acid reduces the risk of in-hospital seizure without increasing the risk of transfusion among cardiac surgery patients. METHODS: We conducted a multicenter, double dummy, blinded, randomized controlled trial of patients recruited by convenience sampling in academic hospitals undergoing cardiac surgery with cardiopulmonary bypass. Between September 17, 2019, and November 28, 2023, a total of 3242 patients from 16 hospitals in 6 countries were randomly assigned (1:1 ratio) to receive either intravenous tranexamic acid (control) through surgery or topical tranexamic acid (treatment) at the end of surgery. The primary outcome was seizure, and the secondary outcome was red blood cell transfusion. After the last planned interim analysis, when 75% of anticipated participants had completed follow up, the data and safety monitoring board recommended to terminate the trial, and upon unblinding, the operations committee stopped the trial for safety. RESULTS: Among 3242 randomized patients (mean age, 66.0 years; 77.7% male), in-hospital seizure occurred in 4 of 1624 patients (0.2%) in the topical group, and 11 of 1628 patients (0.7%) in the intravenous group (absolute risk difference, -0.5% [95% CI, -0.9 to 0.03]; P=0.07). Red blood cell transfusion occurred in 570 patients (35.1%) in the topical group and in 433 (26.8%) in the intravenous group (absolute risk difference, 8.3% [95% CI, 5.2-11.5]; P=0.007). The absolute risk difference in transfusion of ≥4 units of red blood cells in the topical group compared with the intravenous group was 8.2% (95% CI, 3.4-12.9). CONCLUSIONS: Among patients undergoing cardiac surgery, topical administration of tranexamic acid resulted in an 8.3% absolute increase in transfusion without reducing the incidence of seizure, compared with intravenous tranexamic acid. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT03954314.
Anesthesia McMaster University Hamilton ON Canada
Auckland City Hospital New Zealand
Centre de Recherche du Centre Hospitalier de l'Université de Montréal
Department of Anesthesiology Faculty of Medicine University of Malaya Kuala Lumpur Malaysia
Department of Cardiac Surgery Hospital Agel Trinec Podlesi Trinec Czech Republic
Department of Surgery Case Western Reserve University Cleveland OH
Departments of Health Research Methods Evidence and Impact McMaster University Hamilton ON Canada
E Meshalkin National Medical Research Center Novosibirsk Russia
Hamilton Health Sciences Hamilton General Hospital Ontario Canada
Institut Universitaire de Cardiologie et de Pneumologie de Québec Université Laval Québec Canada
Kelowna General Hospital BC Canada
Medicine McMaster University Hamilton ON Canada
Montreal Heart Institute University of Montréal QC Canada
New Brunswick Heart Centre Saint John Canada
Petrovsky National Centre of Surgery Moscow Russia
Population Health Research Institute Hamilton ON Canada
Saint Petersburg State University Hospital Russia
School of Nursing McMaster University Hamilton ON Canada
Shanghai Jiao Tong University School of Medicine China
Surgery McMaster University Hamilton ON Canada
Thrombosis and Atherosclerosis Research Institute McMaster University Hamilton ON Canada
Citace poskytuje Crossref.org
ClinicalTrials.gov
NCT03954314